At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
placebo co-ingestion +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Vinegar Co-ingestion on Postprandial Glucose Control in Type 2 Diabetes Patients
In Brief
A clinical study evaluating placebo co-ingestion and vinegar co-ingestion for Type 2 Diabetes Mellitus. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The main objective of this study is to assess the acute effect of co-ingested vinegar on postprandial plasma glucose levels in type 2 diabetes patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes Mellitus
CountriesNetherlands
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2010
First PostedJan 2011
Primary CompletionMar 2011
TodayJul 2026
First PostedJan 19, 2011
Enrollment StartSep 1, 2010
Primary CompletionMar 1, 2011
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 15.5 years ago
Interventions
placebo co-ingestiondietary
25 ml water co-ingested with a glucose-containing beverage
vinegar co-ingestiondietary
25 ml vinegar (1 g acetic acid) co-ingested with a glucose-containing beverage